Effects of Salmeterol Xinafoate and Fluticasone Propionate on Immunological Activation of Human Cultured Mast Cells
Background: The clinical efficacy of combination therapy comprising a long acting β2-agonist (LABA) and corticosteroid is widely recognized for the treatment of adult asthma. Here we examine the effect of salmeterol xinafoate (SX) and fluticasone propionate (FP) alone and in combination on the immun...
Main Authors: | Hirotomo Akabane, Masayuki Murata, Masafumi Kubota, Eiji Takashima, Hiroyuki Tanaka, Naoki Inagaki, Michiaki Horiba, Hiroichi Nagai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015309941 |
Similar Items
-
Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01) -
Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01) -
Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01) -
In vitro aerodynamic analysis of co-spray dried fluticasone propionate (FP) and salmeterol xinafoate (SX) dry powder inhalation aerosols with lactose-alternative excipient
by: Malapit, Monica, et al.
Published: (2017) -
Effect of combined application of tiotropium and Salmeterol and fluticasone propionate powder on disease control in stable COPD patients
by: Xiu-Ping Han, et al.
Published: (2016-06-01)